vs

Side-by-side financial comparison of Roivant Sciences Ltd. (ROIV) and Beyond Air, Inc. (XAIR). Click either name above to swap in a different company.

Beyond Air, Inc. is the larger business by last-quarter revenue ($2.2M vs $2.0M, roughly 1.1× Roivant Sciences Ltd.). Beyond Air, Inc. runs the higher net margin — -334.4% vs -13301.2%, a 12966.8% gap on every dollar of revenue. On growth, Beyond Air, Inc. posted the faster year-over-year revenue change (104.7% vs -77.8%). Beyond Air, Inc. produced more free cash flow last quarter ($-4.3M vs $-201.4M). Over the past eight quarters, Beyond Air, Inc.'s revenue compounded faster (116.1% CAGR vs -73.7%).

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Delta Air Lines, Inc. is a major airline in the United States headquartered in Atlanta, Georgia, operating nine hubs, with Hartsfield–Jackson Atlanta International Airport being its largest in terms of total passengers and number of departures. With its regional subsidiaries and contractors operating under the brand name Delta Connection, Delta has over 5,400 flights daily and serves 325 destinations in 52 countries on six continents.

ROIV vs XAIR — Head-to-Head

Bigger by revenue
XAIR
XAIR
1.1× larger
XAIR
$2.2M
$2.0M
ROIV
Growing faster (revenue YoY)
XAIR
XAIR
+182.5% gap
XAIR
104.7%
-77.8%
ROIV
Higher net margin
XAIR
XAIR
12966.8% more per $
XAIR
-334.4%
-13301.2%
ROIV
More free cash flow
XAIR
XAIR
$197.2M more FCF
XAIR
$-4.3M
$-201.4M
ROIV
Faster 2-yr revenue CAGR
XAIR
XAIR
Annualised
XAIR
116.1%
-73.7%
ROIV

Income Statement — Q3 FY2026 vs Q3 FY2026

Metric
ROIV
ROIV
XAIR
XAIR
Revenue
$2.0M
$2.2M
Net Profit
$-265.9M
$-7.3M
Gross Margin
13.7%
Operating Margin
-16966.1%
-300.6%
Net Margin
-13301.2%
-334.4%
Revenue YoY
-77.8%
104.7%
Net Profit YoY
-257.0%
43.7%
EPS (diluted)
$-0.38
$-0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ROIV
ROIV
XAIR
XAIR
Q4 25
$2.0M
$2.2M
Q3 25
$1.6M
$1.8M
Q2 25
$2.2M
$1.8M
Q1 25
$-39.6M
$1.2M
Q4 24
$9.0M
$1.1M
Q3 24
$4.5M
$798.0K
Q2 24
$8.0M
$683.0K
Q1 24
$28.9M
$470.0K
Net Profit
ROIV
ROIV
XAIR
XAIR
Q4 25
$-265.9M
$-7.3M
Q3 25
$-113.5M
$-7.9M
Q2 25
$-223.4M
$-7.7M
Q1 25
$-206.5M
$-8.0M
Q4 24
$169.4M
$-13.0M
Q3 24
$-230.2M
$-13.4M
Q2 24
$95.3M
$-12.2M
Q1 24
$-151.1M
$-13.7M
Gross Margin
ROIV
ROIV
XAIR
XAIR
Q4 25
13.7%
Q3 25
-16.4%
Q2 25
8.9%
Q1 25
-2.8%
Q4 24
-20.1%
Q3 24
-135.8%
Q2 24
-48.6%
Q1 24
-109.4%
Operating Margin
ROIV
ROIV
XAIR
XAIR
Q4 25
-16966.1%
-300.6%
Q3 25
-19492.9%
-421.4%
Q2 25
-13130.0%
-432.8%
Q1 25
674.8%
-622.6%
Q4 24
-3042.6%
-1021.6%
Q3 24
-7636.0%
-1608.1%
Q2 24
-1279.5%
-1988.3%
Q1 24
-919.5%
-2687.9%
Net Margin
ROIV
ROIV
XAIR
XAIR
Q4 25
-13301.2%
-334.4%
Q3 25
-7225.9%
-436.7%
Q2 25
-10292.9%
-437.0%
Q1 25
521.8%
-697.4%
Q4 24
1878.3%
-1215.7%
Q3 24
-5143.8%
-1673.9%
Q2 24
1192.7%
-1786.4%
Q1 24
-522.3%
-2916.4%
EPS (diluted)
ROIV
ROIV
XAIR
XAIR
Q4 25
$-0.38
$-0.85
Q3 25
$-0.17
$-1.25
Q2 25
$-0.33
$-1.53
Q1 25
$-0.28
$13.26
Q4 24
$0.23
$-2.96
Q3 24
$-0.31
$-5.67
Q2 24
$0.12
$-5.32
Q1 24
$-0.02
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ROIV
ROIV
XAIR
XAIR
Cash + ST InvestmentsLiquidity on hand
$4.5B
$11.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.3B
$8.1M
Total Assets
$5.2B
$36.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ROIV
ROIV
XAIR
XAIR
Q4 25
$4.5B
$11.7M
Q3 25
$4.4B
$10.7M
Q2 25
$4.5B
$6.5M
Q1 25
$4.9B
$6.9M
Q4 24
$5.1B
$10.9M
Q3 24
$5.4B
$28.4M
Q2 24
$5.7B
$21.4M
Q1 24
$6.5B
$34.5M
Total Debt
ROIV
ROIV
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$11.8M
Q3 24
$12.5M
Q2 24
$311.7M
$17.5M
Q1 24
$430.6M
$17.5M
Stockholders' Equity
ROIV
ROIV
XAIR
XAIR
Q4 25
$4.3B
$8.1M
Q3 25
$4.4B
$12.7M
Q2 25
$4.3B
$9.9M
Q1 25
$4.7B
$13.6M
Q4 24
$5.2B
$17.6M
Q3 24
$5.2B
$28.1M
Q2 24
$5.4B
$16.1M
Q1 24
$6.0B
$25.0M
Total Assets
ROIV
ROIV
XAIR
XAIR
Q4 25
$5.2B
$36.8M
Q3 25
$5.1B
$31.0M
Q2 25
$5.0B
$28.1M
Q1 25
$5.4B
$30.1M
Q4 24
$5.8B
$34.1M
Q3 24
$6.2B
$53.0M
Q2 24
$6.5B
$46.5M
Q1 24
$7.2B
$57.0M
Debt / Equity
ROIV
ROIV
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.67×
Q3 24
0.44×
Q2 24
0.06×
1.08×
Q1 24
0.07×
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ROIV
ROIV
XAIR
XAIR
Operating Cash FlowLast quarter
$-196.5M
$-4.2M
Free Cash FlowOCF − Capex
$-201.4M
$-4.3M
FCF MarginFCF / Revenue
-10076.0%
-193.8%
Capex IntensityCapex / Revenue
246.9%
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M
$-22.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ROIV
ROIV
XAIR
XAIR
Q4 25
$-196.5M
$-4.2M
Q3 25
$-185.7M
$-4.5M
Q2 25
$-204.4M
$-4.5M
Q1 25
$-172.6M
$-7.0M
Q4 24
$-207.3M
$-7.7M
Q3 24
$-266.8M
$-13.3M
Q2 24
$-192.8M
$-10.2M
Q1 24
$-108.5M
$-10.7M
Free Cash Flow
ROIV
ROIV
XAIR
XAIR
Q4 25
$-201.4M
$-4.3M
Q3 25
$-193.5M
$-4.7M
Q2 25
$-208.4M
$-4.7M
Q1 25
$-173.4M
$-8.5M
Q4 24
$-209.1M
$-8.3M
Q3 24
$-267.8M
$-14.5M
Q2 24
$-193.8M
$-12.9M
Q1 24
$-108.8M
$-12.7M
FCF Margin
ROIV
ROIV
XAIR
XAIR
Q4 25
-10076.0%
-193.8%
Q3 25
-12317.8%
-258.5%
Q2 25
-9604.5%
-268.4%
Q1 25
438.1%
-733.9%
Q4 24
-2318.5%
-771.5%
Q3 24
-5984.4%
-1819.9%
Q2 24
-2425.5%
-1881.8%
Q1 24
-376.1%
-2692.8%
Capex Intensity
ROIV
ROIV
XAIR
XAIR
Q4 25
246.9%
1.5%
Q3 25
499.6%
13.5%
Q2 25
185.9%
11.3%
Q1 25
-2.0%
130.0%
Q4 24
20.3%
50.1%
Q3 24
22.3%
147.2%
Q2 24
12.1%
391.4%
Q1 24
1.2%
410.9%
Cash Conversion
ROIV
ROIV
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons